OTCMKTS:BFNH BioForce Nanosciences (BFNH) Stock Price, News & Analysis $0.85 +0.05 (+6.49%) As of 08/28/2025 10:45 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartEarningsSEC FilingsShort InterestBuy This Stock About BioForce Nanosciences Stock (OTCMKTS:BFNH) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get BioForce Nanosciences alerts:Sign Up Key Stats Today's Range$0.66▼$0.8550-Day Range$0.40▼$0.8852-Week Range$0.33▼$1.27Volume2,300 shsAverage Volume912 shsMarket Capitalization$28.49 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview BioForce Nanosciences Holdings, Inc. focuses on providing natural vitamins, minerals, other nutritional supplements, powders, and beverages for individuals in various age ranges. The company offers private label products with distributors and manufacturing providers. It sells its nutrition supplements to retailers, sporting goods retailers, supermarkets, mass merchandisers, and online at www.bioforceeclipse.com, as well as through social media and telemarketing channels. BioForce Nanosciences Holdings, Inc. is based in Virginia Beach, Virginia. Read More Receive BFNH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BioForce Nanosciences and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BFNH Stock News HeadlinesBioForce Nanosciences (OTCMKTS:BFNH) Stock Price Down 0.8% - Here's What HappenedAugust 20, 2025 | americanbankingnews.comBFNH BioForce Nanosciences Holdings, Inc. - Seeking AlphaJuly 31, 2025 | seekingalpha.comBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA or Bitcoin, but by owning a simple index fund. It sounds impossible. Yet it happened – just a short time ago. Now a legendary figure says: "Brace yourselves. It's about to happen here, in America. But fair warning – it could be the worst thing that ever happens to you." This story has received little coverage in the press. But if history repeats, it could bump tens of millions of Americans into a 7-figure net worth practically overnight. | Banyan Hill Publishing (Ad)Building a DNA nanoparticle to be both carrier and medicineFebruary 6, 2024 | msn.comBiomedical Applications Of Nanoscale Devices Market Report Include Detail about Competitor Analysis 2023-2030April 22, 2023 | marketwatch.comBioForce Nanosciences Holdings, Inc. (BFNH)August 20, 2022 | ca.finance.yahoo.comBioForce Nanosciences Holdings Inc (BFNH)January 23, 2022 | nasdaq.comBioForce Nanosciences Holdings Inc.August 25, 2021 | barrons.comSee More Headlines BFNH Stock Analysis - Frequently Asked Questions How have BFNH shares performed this year? BioForce Nanosciences' stock was trading at $0.3415 at the beginning of the year. Since then, BFNH stock has increased by 148.8% and is now trading at $0.8498. How were BioForce Nanosciences' earnings last quarter? BioForce Nanosciences Holdings Inc. (OTCMKTS:BFNH) issued its quarterly earnings data on Tuesday, May, 13th. The company reported ($0.03) earnings per share for the quarter. How do I buy shares of BioForce Nanosciences? Shares of BFNH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of BioForce Nanosciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that BioForce Nanosciences investors own include Nano One Materials (NANO) and Charlotte's Web (CWBHF). Company Calendar Last Earnings5/13/2025Today8/30/2025Next Earnings (Estimated)11/06/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry MED - BIOMED/GENE Sub-IndustryMeasuring And Control Equipment Current SymbolOTCMKTS:BFNH CIK1310488 Webwww.bioforceeclipse.com Phone(757) 306-6090Fax757-306-6092Employees2Year FoundedN/AProfitability EPS (Trailing Twelve Months)($0.04) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$490 thousand Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-30,300.56% Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($0.01) per share Price / Book-84.98Miscellaneous Outstanding Shares33,520,000Free Float20,267,000Market Cap$28.49 million OptionableNot Optionable Beta-1.11 Social Links 5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report This page (OTCMKTS:BFNH) was last updated on 8/30/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | SponsoredNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioForce Nanosciences Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioForce Nanosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
